Treatment Guidelines from The Medical Letter
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Drugs for HIV Infection

Antiretroviral therapy is recommended for all HIV-infected patients, both to reduce the risk of disease progression and to prevent transmission of the virus to others. Various guidelines for treatment of HIV infection are available.1-4

Antiretroviral treatment most often includes a "backbone" of two nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) and a third drug, which can be a non-nucleoside reverse transcriptase inhibitor (NNRTI), a protease inhibitor (PI), an integrase strand transfer inhibitor (INSTI), or a CCR5 antagonist. Preferred and alternative regimens for treatment-naive patients are listed in Table 1. Antiretroviral therapy is often complicated by adverse effects and interactions with other drugs, some of which are listed in Tables 3 and 5. Drug-resistance testing is recommended before antiretroviral drugs ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 138
 Downloadable, electronic issue - $45

Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian